2018 Launch Sponsor

Cambridge Design Partnership

2018 Associate Sponsors

iO life science

2018 Technology Sponsors

Adare Pharmaceuticals
AdminMed
Afecta Pharmaceuticals
Drug Delivery Experts
Keck Graduate Institute
Phylogica
Portal Instruments
Sorrel Medical
Starpharma
Universal Stabilization Technologies

2018 Exhibitors

MedinCell
Polar Leasing
True Concepts Medical

2018 Supporting Partners

California Life Science Association

2018 Media Partners

Big3Bio
Drug Development & Delivery
OndrugDelivery
PharmaCircle
pharmaphorum
SciDoc Publishers
Technology Networks

  • April 24, 2018

  • Roche’s Dr Barbara Lueckel Reviews the 2017 Drug Delivery Industry

    Chair of the Partnership Opportunities in Drug Delivery (PODD) event, Dr Barbara Lueckel, Head of Research and Technologies Partnering at Roche, presents an annual year-in-review of the drug delivery landscape from 2017. Dr Lueckel’s opening remarks are a highlight of PODD every year, and we’re excited to have her return as program chair for the […]

    Chair of the Partnership Opportunities in Drug Delivery (PODD) event, Dr Barbara Lueckel, Head of Research and Technologies Partnering at Roche, presents an annual year-in-review of the drug delivery landscape from 2017. Dr Lueckel’s opening remarks are a highlight of PODD every year, and we’re excited to have her return as program chair for the 2018 event, coming up on October 17-18 in Boston.

    About Dr Lueckel:
    Since end of 2014, Barbara leads the Research & Technologies Partnering (RTP) team belonging to the Innovation Partnering group in Roche Partnering. RTP team members lead evaluations & negotiations with biotech companies in an effort to enhance the discovery efforts of Roche’s Research & Early Development organization (pRED) across all of its therapeutic areas – either applying technology platforms to targets or molecules of interest to pRED (including drug delivery), or collaborating on early stage molecules. RTP team members are also responsible for alliance management of the resulting license agreements. Barbara joined Roche in 2007 as a Global Drug Delivery Evaluator, and transitioned to the Research & Technologies Partnering team in 2012. She is trained as a pharmacist with a PhD from the University of Basel.


    To listen to the audio, please fill out the contact form below.

    Read More

  • March 23, 2018

  • Inaugural West Coast Drug Delivery Event Announced for May 2018

    New York, NY: March 15, 2018 – The Conference Forum is pleased to bring the inaugural Drug Delivery Design & Partnering conference to the Mark Hopkins Intercontinental Hotel in San Francisco on May 21-22, 2018. Organized by the company’s PODD team, this west coast event is dedicated to meeting the design needs of drug delivery […]

    New York, NY: March 15, 2018 – The Conference Forum is pleased to bring the inaugural Drug Delivery Design & Partnering conference to the Mark Hopkins Intercontinental Hotel in San Francisco on May 21-22, 2018. Organized by the company’s PODD team, this west coast event is dedicated to meeting the design needs of drug delivery systems from a variety of different industry perspectives.

    “At this inaugural event, we are bringing together physicians, patients, KOLs and industry to understand and discuss how to improve the design and development of drug delivery systems to better meet the needs of patients,” said conference producer Michelle McDermott.

    Led by chair Dr Ann Daugherty, Genentech, the first day of the program opens with observations on key trends in drug delivery. Dr Daugherty will moderate the first physicians’ POV panel on current and future drug delivery needs. Panelists include Dr Mark Blumenkranz of Stanford University, Dr Krishnan Chakravaty of the University of California, San Diego, Dr Bruce Kovacs of Afecta Pharmaceuticals/USC, and Dr Julia Ljubimova of Cedars-Sinai.

    The patient perspective follows with a panel on what patients want from drug delivery technologies. The spotlight turns to pharma companies, who discuss their current needs, partnering philosophy and scouting interests with Dr Daugherty, Dr John Higgins, Merck, Dr Sudeshna Dutta Ray, Amgen and Dr James Cunningham, Allergan.

    The program continues in the afternoon with the opportunity to assess a wide variety of drug delivery technologies in “quick fire” presentations in two tracks. Track One on Formulation Technologies is chaired by Dr Cunningham. Track Two on Device Technologies is chaired by Sheldon Moberg of Amgen.

    Day two kicks off with Dr Michael Blum of UCSF School of Medicine, who delivers the personalized medicine KOL perspective for drug delivery. Cambridge Design Partnership’s, Uri Barach will walk attendees through the design innovation process and Dr Jonathan Usuka, McKinsey will give the run down on the evolving digital R&D landscape and the impact on drug delivery.

    The morning continues with a Novartis case study on connected smart devices given by Dr Gabriel Iobbi. Dr Sherri Biondi of MedImmune then discusses device design, in particular the current thinking on integrating human factors with digital technologies to increase patient adherence and satisfaction.

    Next, Brent Ahrens of Canaan Partners, Andrew Farquharson of InCube Ventures and Dr Garrett Vygantas of OSF Healthcare Ventures join together to discuss investor perspectives on how analysts and investors look at drug delivery and what they want to see. Finally, Dr John Patton of Dance Biopharma talks about lessons learned from past designs and what we should be aware of for the future.

    For more information, visit Drug Delivery Design & Partnering conference.

     

    About the Conference Forum

    The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance patient-centered clinical research and drug delivery systems.

    Read More